sodium fluoride has been researched along with Arteriosclerosis, Coronary in 40 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with stable coronary artery disease (CAD) and high-risk plaques (HRPs) on coronary computed tomography angiography (CTA), we sought to define qualitative and quantitative CTA predictors of abnormal coronary 18F-sodium fluoride uptake (18F-NaF) by positron emission tomography (PET)." | 7.96 | Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography. ( Berman, DS; Cadet, S; Chang, HJ; Dey, D; Dweck, MR; Friedman, JD; Huynh, PT; Kwiecinski, J; Lee, SE; Newby, DE; Otaki, Y; Slomka, PJ; Tamarappoo, B; Yun, M, 2020) |
| "A significant majority of atherosclerotic plaque ruptures occur in coronary arteries exhibiting none or only modest luminal narrowing on coronary angiography." | 6.49 | Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. ( Chen, W; Dilsizian, V, 2013) |
| "The aim of this study was to assess coronary artery and aortic calcification in healthy controls, angina pectoris patients, and prostate cancer patients using 18F-sodium fluoride PET/computed tomography (NaF-PET/CT)." | 5.22 | Assessing Coronary Artery and Aortic Calcification in Patients with Prostate Cancer Using ( Alavi, A; Borja, AJ; Høilund-Carlsen, PF; Jin, KY; Kothekar, E; Lau, HC; Ng, SJ; Raynor, WY; Revheim, ME; Rojulpote, C; Seraj, SM; Taghvaei, R; Werner, TJ; Zhang, V, 2022) |
| "In patients with stable coronary artery disease (CAD) and high-risk plaques (HRPs) on coronary computed tomography angiography (CTA), we sought to define qualitative and quantitative CTA predictors of abnormal coronary 18F-sodium fluoride uptake (18F-NaF) by positron emission tomography (PET)." | 3.96 | Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography. ( Berman, DS; Cadet, S; Chang, HJ; Dey, D; Dweck, MR; Friedman, JD; Huynh, PT; Kwiecinski, J; Lee, SE; Newby, DE; Otaki, Y; Slomka, PJ; Tamarappoo, B; Yun, M, 2020) |
| "Ruptured coronary atherosclerotic plaques commonly cause acute myocardial infarction." | 2.82 | Motion Correction of 18F-NaF PET for Imaging Coronary Atherosclerotic Plaques. ( Berman, DS; Dey, D; Dweck, MR; Fletcher, A; Germano, G; Joshi, NV; Li, D; Motwani, M; Newby, DE; Rubeaux, M; Slomka, PJ; Thomson, LE, 2016) |
| "Activity was higher in patients with coronary atherosclerosis (n = 106) versus control subjects (1." | 2.77 | Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. ( Boon, NA; Chow, MW; Dweck, MR; Fletcher, AM; Jones, C; Joshi, NV; McKillop, G; Newby, DE; Richardson, H; Rudd, JH; van Beek, EJ; White, A; Williams, MC, 2012) |
| "A significant majority of atherosclerotic plaque ruptures occur in coronary arteries exhibiting none or only modest luminal narrowing on coronary angiography." | 2.49 | Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. ( Chen, W; Dilsizian, V, 2013) |
| "To assess whether coronary atherosclerotic plaque activity as assessed by noninvasive imaging is associated with recurrent coronary events in patients with myocardial infarction." | 1.91 | Coronary Atherosclerotic Plaque Activity and Future Coronary Events. ( Adamson, PD; Arumugam, P; Berman, D; Bularga, A; Calvert, PA; Daghem, M; Dawson, D; Dey, D; Dweck, MR; Fletcher, A; Forsyth, L; Greenwood, JP; Kwiecinski, J; Lee, RJ; Lewis, S; Meah, MN; Mills, NL; Moss, A; Murdoch, L; Newby, DE; Rudd, JHF; Sabharwal, N; Slomka, P; Townend, JN; Tzolos, E; van Beek, EJR; Verjans, J; Wang, KL; Williams, MC, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 24 (60.00) | 24.3611 |
| 2020's | 16 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwiecinski, J | 6 |
| Tzolos, E | 2 |
| Fletcher, AJ | 1 |
| Nash, J | 1 |
| Meah, MN | 2 |
| Cadet, S | 3 |
| Adamson, PD | 3 |
| Grodecki, K | 1 |
| Joshi, N | 1 |
| Williams, MC | 4 |
| van Beek, EJR | 2 |
| Lai, C | 1 |
| Tavares, AAS | 1 |
| MacAskill, MG | 1 |
| Dey, D | 5 |
| Baker, AH | 1 |
| Leipsic, J | 1 |
| Berman, DS | 5 |
| Sellers, SL | 1 |
| Newby, DE | 10 |
| Dweck, MR | 12 |
| Slomka, PJ | 6 |
| Raynor, WY | 1 |
| Borja, AJ | 1 |
| Zhang, V | 1 |
| Kothekar, E | 1 |
| Lau, HC | 1 |
| Ng, SJ | 1 |
| Seraj, SM | 1 |
| Rojulpote, C | 1 |
| Taghvaei, R | 1 |
| Jin, KY | 1 |
| Werner, TJ | 1 |
| Høilund-Carlsen, PF | 2 |
| Alavi, A | 5 |
| Revheim, ME | 1 |
| Moss, A | 1 |
| Daghem, M | 1 |
| Wang, KL | 1 |
| Bularga, A | 1 |
| Fletcher, A | 2 |
| Dawson, D | 1 |
| Arumugam, P | 1 |
| Sabharwal, N | 1 |
| Greenwood, JP | 1 |
| Townend, JN | 1 |
| Calvert, PA | 2 |
| Rudd, JHF | 1 |
| Berman, D | 1 |
| Verjans, J | 1 |
| Slomka, P | 1 |
| Forsyth, L | 1 |
| Murdoch, L | 1 |
| Lee, RJ | 1 |
| Lewis, S | 1 |
| Mills, NL | 2 |
| Bing, R | 1 |
| Ryoo, HG | 1 |
| Paeng, JC | 3 |
| Koo, BK | 3 |
| Cheon, GJ | 1 |
| Lee, DS | 1 |
| Kang, KW | 1 |
| Guaraldi, G | 2 |
| Milic, J | 2 |
| Prandini, N | 2 |
| Ligabue, G | 2 |
| Esposito, F | 2 |
| Ciusa, G | 1 |
| Malagoli, A | 2 |
| Scaglioni, R | 2 |
| Besutti, G | 2 |
| Beghetto, B | 2 |
| Nardini, G | 2 |
| Roncaglia, E | 2 |
| Mussini, C | 2 |
| Raggi, P | 5 |
| Fayad, ZA | 2 |
| Robson, PM | 2 |
| Hayrapetian, A | 1 |
| Berenji, GR | 2 |
| Nguyen, KL | 1 |
| Li, Y | 2 |
| Osborne, MT | 1 |
| Abbasi, TA | 1 |
| Albaghdadi, MS | 1 |
| Abele, J | 2 |
| Dietz, M | 1 |
| Chironi, G | 1 |
| Faraggi, M | 1 |
| Lassen, ML | 2 |
| Mayer, J | 1 |
| Jin, Y | 1 |
| Wurster, TH | 1 |
| Makowski, MR | 1 |
| Kolbitsch, C | 1 |
| Lee, JM | 2 |
| Bang, JI | 2 |
| Hwang, D | 1 |
| Park, J | 2 |
| Zhang, J | 2 |
| Yaliang, T | 1 |
| Suh, M | 1 |
| Shiono, Y | 1 |
| Kubo, T | 2 |
| Akasaka, T | 2 |
| Strauss, HW | 2 |
| Narula, J | 3 |
| Bellinge, JW | 2 |
| Francis, RJ | 2 |
| Majeed, K | 2 |
| Watts, GF | 1 |
| Schultz, CJ | 2 |
| Nakahara, T | 1 |
| Senior, P | 1 |
| Shahbaz, S | 1 |
| Kaul, P | 1 |
| Hung, R | 1 |
| Coulden, R | 1 |
| Yeung, R | 1 |
| Zaha, VG | 1 |
| Joshi, PH | 1 |
| McGuire, DK | 1 |
| Carr, SS | 1 |
| Jones, J | 1 |
| Hong, I | 1 |
| Moghbel, MC | 1 |
| Gerke, O | 1 |
| Kolossváry, M | 1 |
| Merkely, B | 1 |
| Maurovich-Horvat, P | 1 |
| Braglia, G | 1 |
| Lee, SE | 1 |
| Tamarappoo, B | 1 |
| Otaki, Y | 1 |
| Huynh, PT | 1 |
| Friedman, JD | 1 |
| Yun, M | 1 |
| Chang, HJ | 1 |
| Germano, G | 2 |
| Moss, AJ | 1 |
| Chen, W | 1 |
| Dilsizian, V | 1 |
| Joshi, NV | 4 |
| Vesey, AT | 1 |
| Shah, AS | 1 |
| Craighead, FH | 1 |
| Yeoh, SE | 1 |
| Wallace, W | 1 |
| Salter, D | 1 |
| Fletcher, AM | 2 |
| van Beek, EJ | 2 |
| Flapan, AD | 1 |
| Uren, NG | 1 |
| Behan, MW | 1 |
| Cruden, NL | 1 |
| Fox, KA | 1 |
| Rudd, JH | 3 |
| Morbelli, S | 1 |
| Fiz, F | 1 |
| Piccardo, A | 1 |
| Picori, L | 1 |
| Massollo, M | 1 |
| Pestarino, E | 1 |
| Marini, C | 1 |
| Cabria, M | 1 |
| Democrito, A | 1 |
| Cittadini, G | 1 |
| Villavecchia, G | 1 |
| Bruzzi, P | 1 |
| Sambuceti, G | 1 |
| Vesey, A | 1 |
| McKenney-Drake, ML | 1 |
| Territo, PR | 1 |
| Salavati, A | 1 |
| Houshmand, S | 1 |
| Persohn, S | 1 |
| Liang, Y | 1 |
| Alloosh, M | 1 |
| Moe, SM | 1 |
| Weaver, CM | 1 |
| Sturek, M | 1 |
| Rubeaux, M | 1 |
| Motwani, M | 1 |
| Thomson, LE | 1 |
| Li, D | 1 |
| Trivieri, MG | 1 |
| Abgral, R | 1 |
| Karakatsanis, NA | 1 |
| Contreras, J | 1 |
| Gidwani, U | 1 |
| Narula, JP | 1 |
| Fuster, V | 1 |
| Kovacic, JC | 1 |
| Cal-Gonzalez, J | 1 |
| Li, X | 1 |
| Heber, D | 1 |
| Rausch, I | 1 |
| Moore, SC | 1 |
| Schäfers, K | 1 |
| Hacker, M | 1 |
| Beyer, T | 1 |
| Shaba, WF | 1 |
| Tafti, B | 1 |
| Yevdayev, E | 1 |
| Dadparvar, S | 1 |
| Chow, MW | 1 |
| Jones, C | 1 |
| Richardson, H | 1 |
| White, A | 1 |
| McKillop, G | 1 |
| Boon, NA | 1 |
| George, RT | 1 |
| Mohler, ER | 1 |
| Wilensky, RL | 1 |
| Joshi, FR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Diagnostic Accuracy of 18F-sodium Fluoride Positron Emission Tomography for Identification of High-risk Vulnerable Coronary Atherosclerotic Plaque in Patients With Coronary Artery Disease[NCT02388412] | 96 participants (Anticipated) | Observational [Patient Registry] | 2015-03-31 | Recruiting | |||
| 18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes[NCT03530176] | 98 participants (Actual) | Interventional | 2015-01-01 | Completed | |||
| Dual Antiplatelet Therapy to Inhibit Coronary Atherosclerosis and Myocardial Injury in Patients With Necrotic High-Risk Coronary Plaque Disease[NCT02110303] | Phase 2/Phase 3 | 220 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
| Validation of PET-MRI for Cardiovascular Disease[NCT02988531] | 20 participants (Anticipated) | Interventional | 2017-02-09 | Completed | |||
| Prediction of Recurrent Events With 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients With Myocardial Infarction[NCT02278211] | 706 participants (Actual) | Observational | 2015-10-31 | Completed | |||
| Characterizing Vulnerable Plaques in Non-ST-Elevation Myocardial Infarction Using 18F-NaF Positron Emission Tomography - Cardiac Magnetic Resonance Imaging: A Feasibility Study[NCT02563964] | 10 participants (Actual) | Observational [Patient Registry] | 2017-09-01 | Terminated (stopped due to Logistical reasons and slow recruitment) | |||
| In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer[NCT03943966] | 73 participants (Actual) | Interventional | 2019-11-11 | Completed | |||
| Combined Positron Emission Tomography and Magnetic Resonance Imaging of Coronary Atherothrombosis[NCT03618303] | 40 participants (Anticipated) | Interventional | 2018-07-16 | Recruiting | |||
| Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT[NCT03233243] | Phase 4 | 40 participants (Actual) | Interventional | 2020-07-27 | Completed | ||
| An Observational PET/CT Study Examining the Role of Active Valvular Calcification and Inflammation in Patients With Aortic Stenosis[NCT01358513] | 121 participants (Actual) | Observational | 2010-07-31 | Completed | |||
| SALTIRE II: Bisphosphonates and RANKL Inhibition in Aortic Stenosis[NCT02132026] | Phase 2 | 152 participants (Actual) | Interventional | 2014-11-12 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for sodium fluoride and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Assessing Coronary Artery and Aortic Calcification in Patients with Prostate Cancer Using
Topics: Angina Pectoris; Coronary Artery Disease; Fluorine Radioisotopes; Humans; Male; Positron Emission To | 2022 |
Vulnerable plaque imaging using
Topics: Computed Tomography Angiography; Coronary Artery Disease; Fluorine Radioisotopes; Humans; Movement; | 2020 |
Advances in Quantitative Analysis of
Topics: Coronary Artery Disease; Fluorine Radioisotopes; Humans; Plaque, Atherosclerotic; Positron-Emission | 2021 |
Evolving Role of PET in Detecting and Characterizing Atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Contrast Media; Coronary Artery Disease; Disease Models, An | 2019 |
Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
Topics: Calcinosis; Coronary Angiography; Coronary Artery Disease; Disease Progression; Early Diagnosis; Fem | 2013 |
Will 18F-sodium fluoride PET-CT imaging be the magic bullet for identifying vulnerable coronary atherosclerotic plaques?
Topics: Coronary Artery Disease; Fluorine Radioisotopes; Humans; Multimodal Imaging; Myocardial Infarction; | 2014 |
3 trials available for sodium fluoride and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
Motion Correction of 18F-NaF PET for Imaging Coronary Atherosclerotic Plaques.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Female; Fluorine Radioisotopes; Humans; Image P | 2016 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.
Topics: Aged; Aorta, Thoracic; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; | 2012 |
31 other studies available for sodium fluoride and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Bypass Grafting and Native Coronary Artery Disease Activity.
Topics: Aged; Calcinosis; Calcium; Coronary Angiography; Coronary Artery Disease; Disease Progression; Femal | 2022 |
Coronary Atherosclerotic Plaque Activity and Future Coronary Events.
Topics: Cohort Studies; Coronary Artery Disease; Death; Female; Humans; Male; Myocardial Infarction; Plaque, | 2023 |
Aortic valve and coronary 18F-sodium fluoride activity: a common cause?
Topics: Aortic Valve Stenosis; Coronary Artery Disease; Fluorine Radioisotopes; Humans; Positron Emission To | 2021 |
Clinical implication of 18F-NaF PET/computed tomography indexes of aortic calcification in coronary artery disease patients: correlations with cardiovascular risk factors.
Topics: Aorta; Calcinosis; Coronary Artery Disease; Female; Fluorine Radioisotopes; Humans; Image Processing | 2020 |
Topics: Aged; Coronary Artery Disease; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; HIV Infectio | 2020 |
Topics: Coronary Artery Disease; Fluorine Radioisotopes; Humans; Positron-Emission Tomography; Sodium; Sodiu | 2020 |
Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Coronary Stenosis; Fluorine Radioisotopes; Humans; | 2021 |
Narrowing in on a PET tracer that characterizes coronary atheroma:
Topics: Coronary Artery Disease; Fluorine Radioisotopes; Humans; Plaque, Atherosclerotic; Positron-Emission | 2021 |
Molecular imaging for risk prediction of coronary artery disease: A close or far fetched option?
Topics: Acute Coronary Syndrome; Angiography; Coronary Artery Disease; Humans; Molecular Imaging; Positron-E | 2021 |
Reduced 18F-sodium fluoride activity in coronary plaques after statin therapy.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Humans; Hydroxymethylglutaryl-CoA R | 2021 |
Evaluation of synergistic image registration for motion-corrected coronary NaF-PET-MR.
Topics: Computer Simulation; Coronary Artery Disease; Coronary Vessels; Fluorine Radioisotopes; Humans; Imag | 2021 |
The never ending search for the elusive vulnerable plaque.
Topics: Coronary Artery Disease; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomog | 2017 |
Clinical Relevance of
Topics: Aged; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Steno | 2017 |
Topics: Coronary Artery Disease; Fluorides; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; S | 2017 |
In search of the vulnerable patient or the vulnerable plaque:
Topics: Cardiovascular Diseases; Coronary Artery Disease; Fluorine Radioisotopes; Humans; Plaque, Atheroscle | 2018 |
NaF uptake in unstable plaque: what does fluoride uptake mean?
Topics: Coronary Artery Disease; Correlation of Data; Fluorides; Humans; Positron Emission Tomography Comput | 2018 |
Topics: Adult; Aged; Aged, 80 and over; Calcium; Coronary Artery Disease; Coronary Vessels; Diabetes Complic | 2019 |
Probing for Vulnerable Plaque in Patients With Diabetes Mellitus.
Topics: Coronary Artery Disease; Diabetes Mellitus; Humans; Plaque, Atherosclerotic; Sodium Fluoride | 2019 |
Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software.
Topics: Algorithms; Coronary Artery Disease; Coronary Vessels; Elasticity; Fluorine Radioisotopes; Humans; I | 2020 |
Identification of invasive and radionuclide imaging markers of coronary plaque vulnerability using radiomic analysis of coronary computed tomography angiography.
Topics: Aged; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Endosonography | 2019 |
Molecular Imaging of Vascular Calcification with
Topics: Aged; Coronary Artery Disease; Disease Progression; Female; Fluorine Radioisotopes; HIV; HIV Infecti | 2019 |
Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography.
Topics: Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Fl | 2020 |
Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary
Topics: Aged; Angiography; Coronary Artery Disease; Female; Fluorine Radioisotopes; Gated Blood-Pool Imaging | 2019 |
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Coronary Artery Disease; Coronary Vessels; Female; Fluorine | 2014 |
(18)F-NaF PET Imaging of Early Coronary Artery Calcification.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Diet, Atherogenic; Disease Models, Animal; Disea | 2016 |
Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.
Topics: Adult; Aged; Algorithms; Artifacts; Contrast Media; Coronary Artery Disease; Coronary Vessels; Feasi | 2017 |
Partial volume correction for improved PET quantification in
Topics: Adult; Aged; Coronary Artery Disease; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Pha | 2018 |
Association of vascular fluoride uptake with vascular calcification and coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Coronary Artery Disease; Feasibility Studies; Femal | 2012 |
18F-sodium fluoride positron emission tomography: an in vivo window into coronary atherosclerotic plaque biology.
Topics: Coronary Artery Disease; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Posit | 2012 |
(18)F-fluoride imaging for atherosclerosis.
Topics: Coronary Artery Disease; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Posit | 2012 |
Noninvasive imaging in cardiovascular therapy: the promise of coronary arterial ¹⁸F-sodium fluoride uptake as a marker of plaque biology.
Topics: Atherosclerosis; Biological Transport; Biomarkers; Coronary Artery Disease; Coronary Vessels; Diseas | 2012 |